Developer docs
API playgroundTry for free, no card

Search company profiles

Society for Inherited Metabolic Disorders

Full company profile

uuid003ajey

Namestring
Society for Inherited Metabolic Disorders
Legal namestring
Society for Inherited Metabolic Disorders
Websiteurl
simd.org
Company typeenum
Private
Founded yearint
1978
Descriptiontext

The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society founded in 1978 and headquartered in the United States, dedicated to advancing research, education, and clinical care for inborn errors of metabolism (IEM). Its members are physicians, biochemical geneticists, metabolic dietitians, genetic counselors, laboratorians, and basic/clinical researchers who apply for admission and are approved by member vote. SIMD operates through a Board of Directors (President, President-Elect, Past President, Treasurer, Secretary, Directors-at-Large, and committee chairs) with a new Executive Director (Kristi S. Wees, appointed January 2025) leading day-to-day operations; Leslie Lublink serves as consultant and the Secretariat is hosted at Duke University.

SIMD's core product surface consists of educational and clinical resources rather than commercial technology: the North American Metabolic Academy (NAMA) with over 70 PowerPoint lectures hosted at simdnama.org; the Medical Biochemical Genetics Clinical Core Seminar Series (MBG-CCSS) originating at the University of Colorado Anschutz Medical Campus and distributed via YouTube; IEMbase (freely available at iembase.org) and the Case Database of Inherited Metabolic Disorders (CDB-IMD at imd-casesdatabase.org) for browsing and case sharing; the official journal Molecular Genetics and Metabolism published via Elsevier/ScienceDirect; specialty-bucketed online discussion groups; an awards program (Emmanuel Shapira Award, Buist Founders' Award, SIMD-Hyperion Fellowship, JSIMD Young Investigator Presentation Award); and annual plus ad-hoc virtual programming (Expert Webinars, Fellow Journal Club, FDA/SIMD joint webinars, Laboratory Workgroup Webinar Series).

Revenue mechanics combine annual membership dues tiered from $45 (developing-nation trainee) to $295 (regular and affiliate), annual scientific meeting registration with rotating locations (2024 Charlotte co-located with GMDI; 2027 Tucson; ICIEM 2029 Toronto), pharmaceutical sponsorships at Diamond through Bronze levels (Amgen, BioMarin, PTC Therapeutics, Ultragenyx as core supporters), and Elsevier journal distribution. Financial details are not publicly disclosed (FY2007 fund balance was approximately $316K including a $160K restricted NAMA account). The society maintains formal collaborations with ACMG, GMDI, ICIEM, SSIEM, JSIMD, and FDA/Office of New Drugs, and engages in public-policy advocacy on newborn screening, ACHDNC, and medical foods.

Short descriptiontext

The Society for Inherited Metabolic Disorders (SIMD) is a US 501(c)(3) nonprofit professional society founded in 1978 that serves metabolic medicine physicians, biochemical geneticists, dietitians, genetic counselors, and researchers through education (NAMA, MBG-CCSS), its journal Molecular Genetics and Metabolism, annual meetings, and policy advocacy on newborn screening and rare metabolic disorders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWest Linn, United States
HQ citystring
West Linn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Professional Medical Society, Inherited Metabolic Disorders, Medical Education Programs, Metabolic Disease Research, Biochemical Genetics Training
Industry1 code
1Genetic & Genomic Rare Disease Therapeutics
CodeHLAIAIAAPrimaryYes
NAICS code1 code
  • Professional Organizations81392
Product category
Professional Medical Association
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Membership Dues
TypeSubscription Recurring
Description

Annual dues from members form the primary recurring revenue stream. Dues categories include Regular ($295/yr), Non-Doctoral ($130/yr), Trainee ($130/yr up to 3 years), Affiliate ($295/yr), Emeritus ($0-$95/yr), and Developing Nation ($130/yr or $45/yr for trainees). Dues are invoiced annually in May or June.

simd.org
2Annual Meeting Registration
TypeOne Time License
Description

Registration fees for annual scientific meetings. Meetings frequently co-locate with ACMG, GMDI, or international ICIEM events, generating additional registration revenue. Pharmaceutical company sponsors provide financial support at various levels (Diamond, Platinum, Gold, Silver, Bronze).

simd.org
3Journal Subscription
TypeSubscription Recurring
Description

Annual subscription to Molecular Genetics and Metabolism is included in membership dues (except for Emeritus without MGM option). Individual online access and subscription changes handled through Elsevier.

simd.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details7 tiers
1Regular Member - $295/year
ModelSubscriptionBilling cadenceAnnual
Notes

For physicians and scientists actively involved in clinical or basic research or patient care related to inherited metabolic disorders. Includes MGM journal subscription.

simd.org
2Non-Doctoral Member - $130/year
ModelSubscriptionBilling cadenceAnnual
Notes

For non-physician PhD researchers or other professionals in related fields.

simd.org
3Trainee Member - $130/year
ModelSubscriptionBilling cadenceAnnual
Notes

For trainees in the field. Renewable annually up to 3 years. Includes MGM journal subscription.

simd.org
4Affiliate Membership - $295/year
ModelSubscriptionBilling cadenceAnnual
Notes

For individuals who do not meet other membership categories but share strong interest in advancing SIMD mission. Not eligible to vote or serve on Board.

simd.org
5Emeritus Member - $0 or $95/year
ModelSubscriptionBilling cadenceAnnual
Notes

For active members who have retired from full-time service. $0 option without MGM subscription, $95/yr with MGM subscription option. Same privileges as active members.

simd.org
6Developing/Other Nation Member - $130/year
ModelSubscriptionBilling cadenceAnnual
Notes

Reduced dues for nations classified other than High Income on World Bank List of Economies.

simd.org
7Developing/Other Nation Trainee/Associate - $45/year
ModelSubscriptionBilling cadenceAnnual
Notes

Further discount for associates or trainees in other nations, without journal subscription. Renewable up to 3 years.

simd.org
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society that serves clinicians, scientists, genetic counselors, dietitians, and trainees working in inherited metabolic disorders. It delivers educational programs such as the North American Metabolic Academy (NAMA) and the MBG-CCSS seminar series, operates knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders (CDB-IMD), publishes the Molecular Genetics and Metabolism journal, and convenes its Annual Scientific Meeting. SIMD also advocates for the field through policy engagement and partnerships with ACGME, ACIMD, ABMGG, JSIMD, the Gemon Foundation, and NORD.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • NAMA offers >70 professional educational presentations covering broad range of metabolic disease topics
+2 more records
Product overview1 text field

SIMD is a professional organization that provides educational resources, publications, and member services for professionals in inherited metabolic disorders. Its core offerings include the North American Metabolic Academy (NAMA) with over 70 PowerPoint presentations, the Medical Biochemical Genetics Clinical Core Seminar Series (MBG-CCSS), and the Molecular Genetics and Metabolism journal as its official publication. Additional services include discussion groups organized by professional category (Clinicians, Dietitians, Nurses, Laboratorians, Counselors, Basic/Clinical Research), an awards program recognizing excellence in the field, and access to knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders.

Product and service8 records
1North American Metabolic Academy (NAMA)
CategoryEducation program
Description

Formal education program providing specialized training in inherited metabolic disorders for clinicians, scientists, genetic counselors, and dietitians

2MBG-CCSS Seminar Series
CategoryEducation program
Description

Regular seminar series for metabolic disease specialists delivered through SIMD's online educational platform

3IEMbase
CategoryKnowledgebase reference resource
Description

Specialized knowledgebase for inherited metabolic disorders used by metabolic disease professionals

4Case Database of Inherited Metabolic Disorders (CDB-IMD)
CategoryClinical reference database
Description

Case database of inherited metabolic disorders with an Aggregated website for case submissions and reference

5Annual Scientific Meeting
CategoryConference
Description

SIMD's annual scientific meeting for metabolic disease clinicians, researchers, and trainees, supported by Diamond, Platinum, Gold, Silver, and Bronze sponsors

6Molecular Genetics and Metabolism Journal
CategoryScientific journal
Description

Peer-reviewed scientific journal published in partnership with Elsevier, focused on molecular genetics and metabolism research

7Discussion Groups Platform
CategoryMember engagement platform
Description

Member-only online discussion groups for peer collaboration among SIMD members

8SIMD Awards Program
CategoryAwards program
Description

Society awards recognizing contributions to the inherited metabolic disorders field

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SIMD holds joint sessions with ACMG at annual meetings. 2023 meeting co-located with ACMG in Salt Lake City. 2019 meeting featured joint session in Seattle with ACMG. Ongoing collaboration on meetings and policy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

SIMD2024 annual meeting held in conjunction with GMDI annual meeting immediately following SIMD meeting in Charlotte. Joint sessions and shared attendance.

3International Congress of Inborn Errors of Metabolism (ICIEM)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SIMD co-hosts ICIEM meetings approximately every 4 years. Past: 2013 Barcelona, 2017 Rio de Janeiro. Upcoming: 2029 Toronto. SIMD provides travel awards for trainees to attend.

simd.org
4SSIEM (Society for the Study of Inborn Errors of Metabolism)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SSIEM holds annual meetings in Europe. SIMD lists SSIEM events (2026 Helsinki, 2027 Dublin, 2030 Basel) on meetings page. International collaboration on metabolic disorder research.

simd.org
5Japanese Society for Inherited Metabolic Disorders (JSIMD)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Established 2019 JSIMD Young Investigator Presentation award to bring JSIMD-selected young investigator to SIMD annual meeting. Collaborative recognition of trainees.

simd.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as Non-Commercial/Parent Support Group supporter of SIMD2024. FDA/SIMD Webinars on regulatory perspectives including clinical outcome assessments in clinical trials for IEM.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Non-Commercial supporter of SIMD2024. CHOP faculty participate in SIMD education including MBG-CCSS lectures and award recipients.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Non-Commercial/Parent Support Group supporter of SIMD2024. Represents patient community for phenylketonuria.

9United Mitochondrial Disease Foundation
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Non-Commercial supporter of SIMD2024. Patient advocacy organization for mitochondrial disorders.

simd.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Japanese Society for Inherited Metabolic Disorders (JSIMD)
TypeDirect peer
Description

National counterpart IEM society. SIMD and JSIMD jointly administer the Young Investigator Presentation Award since 2019, demonstrating formal cross-border peer collaboration on trainee recognition.

2International Congress of Inborn Errors of Metabolism (ICIEM)
TypeDirect peer
Description

Quadrennial international IEM congress co-hosted by SIMD with SSIEM and other societies. Serves the same clinician-researcher audience as SIMD's annual meeting but at global scale (2029 Toronto upcoming).

TypeOthers
Description

Society for molecular pathology professionals including biochemical genetics laboratorians — a SIMD member category. Adjacent specialty with shared laboratory audience but different primary focus.

TypeEmerging player
Description

U.S. society for genetic counselors — a segment SIMD serves through its dedicated Counselor discussion group. Partial overlap on IEM clinical topics but distinct professional identity.

TypeBroad incumbent
Description

Largest U.S. human genetics society with annual meeting drawing 8,000+ attendees. Many SIMD members also attend ASHG; broader scope includes IEM but lacks SIMD's clinical specialty focus.

6European Society of Human Genetics (ESHG)
TypeBroad incumbent
Description

European counterpart to ASHG. Similar broader society model with overlapping IEM basic-research content but different geographic focus than SIMD.

TypeDirect peer
Description

Co-locates annual meetings with SIMD (most recently Charlotte 2024) and serves the dietitian segment of the IEM professional community. Closest operational peer with shared audience and educational programming.

8Society for the Study of Inborn Errors of Metabolism (SSIEM)
TypeDirect peer
Description

European/international IEM society with parallel mission, membership model, and annual meeting structure. SIMD cross-lists SSIEM events on its meetings page, indicating tight functional equivalence as a sister society.

TypeBroad incumbent
Description

Larger medical genetics professional society (3,000+ members) that co-hosts joint sessions with SIMD (Salt Lake City 2023, Seattle 2019). Broader mandate captures overlapping IEM content but lacks SIMD's specialty depth.

TypeOthers
Description

Patient advocacy organization for phenylketonuria, a core SIMD disease area. Listed as a Non-Commercial supporter of SIMD2024. Adjacent ecosystem participant rather than direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Society for Inherited Metabolic Disorders

Professional Medical Associationsimd.org

The Society for Inherited Metabolic Disorders (SIMD) is a US 501(c)(3) nonprofit professional society founded in 1978 that serves metabolic medicine physicians, biochemical geneticists, dietitians, genetic counselors, and researchers through education (NAMA, MBG-CCSS), its journal Molecular Genetics and Metabolism, annual meetings, and policy advocacy on newborn screening and rare metabolic disorders.

What Society for Inherited Metabolic Disorders does

The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society founded in 1978 and headquartered in the United States, dedicated to advancing research, education, and clinical care for inborn errors of metabolism (IEM). Its members are physicians, biochemical geneticists, metabolic dietitians, genetic counselors, laboratorians, and basic/clinical researchers who apply for admission and are approved by member vote. SIMD operates through a Board of Directors (President, President-Elect, Past President, Treasurer, Secretary, Directors-at-Large, and committee chairs) with a new Executive Director (Kristi S. Wees, appointed January 2025) leading day-to-day operations; Leslie Lublink serves as consultant and the Secretariat is hosted at Duke University.

SIMD's core product surface consists of educational and clinical resources rather than commercial technology: the North American Metabolic Academy (NAMA) with over 70 PowerPoint lectures hosted at simdnama.org; the Medical Biochemical Genetics Clinical Core Seminar Series (MBG-CCSS) originating at the University of Colorado Anschutz Medical Campus and distributed via YouTube; IEMbase (freely available at iembase.org) and the Case Database of Inherited Metabolic Disorders (CDB-IMD at imd-casesdatabase.org) for browsing and case sharing; the official journal Molecular Genetics and Metabolism published via Elsevier/ScienceDirect; specialty-bucketed online discussion groups; an awards program (Emmanuel Shapira Award, Buist Founders' Award, SIMD-Hyperion Fellowship, JSIMD Young Investigator Presentation Award); and annual plus ad-hoc virtual programming (Expert Webinars, Fellow Journal Club, FDA/SIMD joint webinars, Laboratory Workgroup Webinar Series).

Revenue mechanics combine annual membership dues tiered from $45 (developing-nation trainee) to $295 (regular and affiliate), annual scientific meeting registration with rotating locations (2024 Charlotte co-located with GMDI; 2027 Tucson; ICIEM 2029 Toronto), pharmaceutical sponsorships at Diamond through Bronze levels (Amgen, BioMarin, PTC Therapeutics, Ultragenyx as core supporters), and Elsevier journal distribution. Financial details are not publicly disclosed (FY2007 fund balance was approximately $316K including a $160K restricted NAMA account). The society maintains formal collaborations with ACMG, GMDI, ICIEM, SSIEM, JSIMD, and FDA/Office of New Drugs, and engages in public-policy advocacy on newborn screening, ACHDNC, and medical foods.

Society for Inherited Metabolic Disorders firmographics

Firmographics
Name
Society for Inherited Metabolic Disorders
Legal name
Society for Inherited Metabolic Disorders
Website
https://simd.org
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
51–100 employees
Short description
The Society for Inherited Metabolic Disorders (SIMD) is a US 501(c)(3) nonprofit professional society founded in 1978 that serves metabolic medicine physicians, biochemical geneticists, dietitians, genetic counselors, and researchers through education (NAMA, MBG-CCSS), its journal Molecular Genetics and Metabolism, annual meetings, and policy advocacy on newborn screening and rare metabolic disorders.
Ownership category
akta.pro rank

Society for Inherited Metabolic Disorders industry classification

Industry
Product category
Professional Medical Association
NAICS
Professional Organizations (81392)
akta.pro primary industry
Genetic & Genomic Rare Disease Therapeutics (HLAIAIAA)

Keywords

  • Professional Medical Society
  • Inherited Metabolic Disorders
  • Medical Education Programs
  • Metabolic Disease Research
  • Biochemical Genetics Training

Where Society for Inherited Metabolic Disorders is headquartered

Location

Headquarters

HQ city
West Linn
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Society for Inherited Metabolic Disorders business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Membership Dues: Annual dues from members form the primary recurring revenue stream. Dues categories include Regular ($295/yr), Non-Doctoral ($130/yr), Trainee ($130/yr up to 3 years), Affiliate ($295/yr), Emeritus ($0-$95/yr), and Developing Nation ($130/yr or $45/yr for trainees). Dues are invoiced annually in May or June.
  2. Annual Meeting Registration: Registration fees for annual scientific meetings. Meetings frequently co-locate with ACMG, GMDI, or international ICIEM events, generating additional registration revenue. Pharmaceutical company sponsors provide financial support at various levels (Diamond, Platinum, Gold, Silver, Bronze).
  3. Journal Subscription: Annual subscription to Molecular Genetics and Metabolism is included in membership dues (except for Emeritus without MGM option). Individual online access and subscription changes handled through Elsevier.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualRegular Member - $295/year
SubscriptionAnnualNon-Doctoral Member - $130/year
SubscriptionAnnualTrainee Member - $130/year
SubscriptionAnnualAffiliate Membership - $295/year
SubscriptionAnnualEmeritus Member - $0 or $95/year
SubscriptionAnnualDeveloping/Other Nation Member - $130/year
SubscriptionAnnualDeveloping/Other Nation Trainee/Associate - $45/year

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Society for Inherited Metabolic Disorders product offering

Product offering

Core offering

The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society that serves clinicians, scientists, genetic counselors, dietitians, and trainees working in inherited metabolic disorders. It delivers educational programs such as the North American Metabolic Academy (NAMA) and the MBG-CCSS seminar series, operates knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders (CDB-IMD), publishes the Molecular Genetics and Metabolism journal, and convenes its Annual Scientific Meeting. SIMD also advocates for the field through policy engagement and partnerships with ACGME, ACIMD, ABMGG, JSIMD, the Gemon Foundation, and NORD.

Product overview

SIMD is a professional organization that provides educational resources, publications, and member services for professionals in inherited metabolic disorders. Its core offerings include the North American Metabolic Academy (NAMA) with over 70 PowerPoint presentations, the Medical Biochemical Genetics Clinical Core Seminar Series (MBG-CCSS), and the Molecular Genetics and Metabolism journal as its official publication. Additional services include discussion groups organized by professional category (Clinicians, Dietitians, Nurses, Laboratorians, Counselors, Basic/Clinical Research), an awards program recognizing excellence in the field, and access to knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders.

Differentiator

Problem solved

Functional benefit

Products and services

  • North American Metabolic Academy (NAMA) Formal education program providing specialized training in inherited metabolic disorders for clinicians, scientists, genetic counselors, and dietitians
  • MBG-CCSS Seminar Series Regular seminar series for metabolic disease specialists delivered through SIMD's online educational platform
  • IEMbase Specialized knowledgebase for inherited metabolic disorders used by metabolic disease professionals
  • Case Database of Inherited Metabolic Disorders (CDB-IMD) Case database of inherited metabolic disorders with an Aggregated website for case submissions and reference
  • Annual Scientific Meeting SIMD's annual scientific meeting for metabolic disease clinicians, researchers, and trainees, supported by Diamond, Platinum, Gold, Silver, and Bronze sponsors
  • Molecular Genetics and Metabolism Journal Peer-reviewed scientific journal published in partnership with Elsevier, focused on molecular genetics and metabolism research
  • Discussion Groups Platform Member-only online discussion groups for peer collaboration among SIMD members
  • SIMD Awards Program Society awards recognizing contributions to the inherited metabolic disorders field

Quantifiable outcome

  • NAMA offers >70 professional educational presentations covering broad range of metabolic disease topics
  • +2 more outcomes

Companies that use Society for Inherited Metabolic Disorders

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles2 records

Society for Inherited Metabolic Disorders technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Society for Inherited Metabolic Disorders partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • American College of Medical Genetics and Genomics (ACMG)coreStrategic or Co-development PartnerSIMD holds joint sessions with ACMG at annual meetings. 2023 meeting co-located with ACMG in Salt Lake City. 2019 meeting featured joint session in Seattle with ACMG. Ongoing collaboration on meetings and policy.
  • Genetic Metabolic Dietitians International (GMDI)coreStrategic or Co-development PartnerSIMD2024 annual meeting held in conjunction with GMDI annual meeting immediately following SIMD meeting in Charlotte. Joint sessions and shared attendance.
  • International Congress of Inborn Errors of Metabolism (ICIEM)coreStrategic or Co-development PartnerSIMD co-hosts ICIEM meetings approximately every 4 years. Past: 2013 Barcelona, 2017 Rio de Janeiro. Upcoming: 2029 Toronto. SIMD provides travel awards for trainees to attend.
  • SSIEM (Society for the Study of Inborn Errors of Metabolism)coreStrategic or Co-development PartnerSSIEM holds annual meetings in Europe. SIMD lists SSIEM events (2026 Helsinki, 2027 Dublin, 2030 Basel) on meetings page. International collaboration on metabolic disorder research.
  • Japanese Society for Inherited Metabolic Disorders (JSIMD)minorStrategic or Co-development PartnerEstablished 2019 JSIMD Young Investigator Presentation award to bring JSIMD-selected young investigator to SIMD annual meeting. Collaborative recognition of trainees.
  • U.S. FDA/Office of New Drugs (OND)minorStrategic or Co-development PartnerListed as Non-Commercial/Parent Support Group supporter of SIMD2024. FDA/SIMD Webinars on regulatory perspectives including clinical outcome assessments in clinical trials for IEM.
  • Children's Hospital of Philadelphia (CHOP)minorStrategic or Co-development PartnerNon-Commercial supporter of SIMD2024. CHOP faculty participate in SIMD education including MBG-CCSS lectures and award recipients.
  • National PKU AllianceminorStrategic or Co-development PartnerNon-Commercial/Parent Support Group supporter of SIMD2024. Represents patient community for phenylketonuria.
  • United Mitochondrial Disease FoundationminorStrategic or Co-development PartnerNon-Commercial supporter of SIMD2024. Patient advocacy organization for mitochondrial disorders.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Society for Inherited Metabolic Disorders competitors and assessment

Company assessment

Direct peers

  • Japanese Society for Inherited Metabolic Disorders (JSIMD): National counterpart IEM society. SIMD and JSIMD jointly administer the Young Investigator Presentation Award since 2019, demonstrating formal cross-border peer collaboration on trainee recognition.
  • International Congress of Inborn Errors of Metabolism (ICIEM): Quadrennial international IEM congress co-hosted by SIMD with SSIEM and other societies. Serves the same clinician-researcher audience as SIMD's annual meeting but at global scale (2029 Toronto upcoming).
  • Genetic Metabolic Dietitians International (GMDI): Co-locates annual meetings with SIMD (most recently Charlotte 2024) and serves the dietitian segment of the IEM professional community. Closest operational peer with shared audience and educational programming.
  • Society for the Study of Inborn Errors of Metabolism (SSIEM): European/international IEM society with parallel mission, membership model, and annual meeting structure. SIMD cross-lists SSIEM events on its meetings page, indicating tight functional equivalence as a sister society.

Others

  • Association for Molecular Pathology (AMP): Society for molecular pathology professionals including biochemical genetics laboratorians — a SIMD member category. Adjacent specialty with shared laboratory audience but different primary focus.
  • National PKU Alliance (NPKUA): Patient advocacy organization for phenylketonuria, a core SIMD disease area. Listed as a Non-Commercial supporter of SIMD2024. Adjacent ecosystem participant rather than direct competitor.

Emerging players

  • National Society of Genetic Counselors (NSGC): U.S. society for genetic counselors — a segment SIMD serves through its dedicated Counselor discussion group. Partial overlap on IEM clinical topics but distinct professional identity.

Broad incumbents

  • American Society of Human Genetics (ASHG): Largest U.S. human genetics society with annual meeting drawing 8,000+ attendees. Many SIMD members also attend ASHG; broader scope includes IEM but lacks SIMD's clinical specialty focus.
  • European Society of Human Genetics (ESHG): European counterpart to ASHG. Similar broader society model with overlapping IEM basic-research content but different geographic focus than SIMD.
  • American College of Medical Genetics and Genomics (ACMG): Larger medical genetics professional society (3,000+ members) that co-hosts joint sessions with SIMD (Salt Lake City 2023, Seattle 2019). Broader mandate captures overlapping IEM content but lacks SIMD's specialty depth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Society for Inherited Metabolic Disorders social profiles

Digital presence

Society for Inherited Metabolic Disorders financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Society for Inherited Metabolic Disorders leadership team

Management profile

Number of profiles

Society for Inherited Metabolic Disorders funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Society for Inherited Metabolic Disorders M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Society for Inherited Metabolic Disorders

What does Society for Inherited Metabolic Disorders do?

The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society that serves clinicians, scientists, genetic counselors, dietitians, and trainees working in inherited metabolic disorders. It delivers educational programs such as the North American Metabolic Academy (NAMA) and the MBG-CCSS seminar series, operates knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders (CDB-IMD), publishes the Molecular Genetics and Metabolism journal, and convenes its Annual Scientific Meeting. SIMD also advocates for the field through policy engagement and partnerships with ACGME, ACIMD, ABMGG, JSIMD, the Gemon Foundation, and NORD.

Is Society for Inherited Metabolic Disorders a public or private company?

Society for Inherited Metabolic Disorders is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Society for Inherited Metabolic Disorders founded?

Society for Inherited Metabolic Disorders was founded in 1978. It employs 51 to 100 people.

Where is Society for Inherited Metabolic Disorders based?

Society for Inherited Metabolic Disorders is headquartered in West Linn, United States, in the North America region.

How does Society for Inherited Metabolic Disorders make money?

Three revenue lines are on record. Membership Dues are the primary driver. The others are annual Meeting Registration and journal Subscription.

Who are Society for Inherited Metabolic Disorders's main competitors?

Direct peers on record are Japanese Society for Inherited Metabolic Disorders (JSIMD), International Congress of Inborn Errors of Metabolism (ICIEM), Genetic Metabolic Dietitians International (GMDI) and Society for the Study of Inborn Errors of Metabolism (SSIEM). Others are Association for Molecular Pathology (AMP) and National PKU Alliance (NPKUA). National Society of Genetic Counselors (NSGC) is listed as an emerging player. Broad incumbents are American Society of Human Genetics (ASHG), European Society of Human Genetics (ESHG) and American College of Medical Genetics and Genomics (ACMG).

Does Society for Inherited Metabolic Disorders have an API?

No public API is recorded for Society for Inherited Metabolic Disorders.

What industry is Society for Inherited Metabolic Disorders in?

Society for Inherited Metabolic Disorders's product category is Professional Medical Association. Its primary akta.pro industry code is HLAIAIAA, Genetic & Genomic Rare Disease Therapeutics. Its NAICS code is 81392.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireTravere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians InternationalTravere Therapeutics will present eight posters on classical homocystinuria at SIMD and GMDI in Charlotte, April 14-20, 2024. The posters cover the HARMONY Phase 3 trial design, COMPOSE Phase 1/2 results, and a dietary management tool. The company highlights pegtibatinase as a potential disease-modifying treatment.GlobeNewswireSynlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual MeetingSynlogic presented positive Phase 2 data for its PKU program at the SIMD 44th Annual Meeting, showing D5-Phe reductions of -33.8% and -42.9% for SYNB1618 and SYNB1934, with a 60% response rate for SYNB1934. The company also shared clinical and preclinical data for its HCU program, and plans to begin a Phase 3 trial in the first half of 2023.GlobeNewswireAcer Therapeutics Announces Presentation of HCP Urea Cycle Disorder Treatment Preference Data at the Society for Inherited Metabolic Disorders Annual Meeting and Provides OLPRUVA™ Program UpdateAcer Therapeutics will present survey data on healthcare provider preferences for Urea Cycle Disorder treatments at the Society for Inherited Metabolic Disorders meeting in March. The company also updated its OLPRUVA launch, with U.S. launch planned for Q2 2023 and drug availability expected by early July 2023.GlobeNewswireReneo Pharmaceuticals to Present Preclinical Mavodelpar (REN001) Data at the Society for Inherited Metabolic Disorders Annual Meeting 2023Reneo Pharmaceuticals will present preclinical data on mavodelpar (REN001) at the Society for Inherited Metabolic Disorders Annual Meeting in Salt Lake City, March 18-21, 2023. The poster shows PPARδ agonist effects on fatty acid metabolism and mitochondrial biogenesis in mice, with the drug in a pivotal trial for primary mitochondrial myopathies.GlobeNewswireSynlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for Inherited Metabolic Disorders 43rd Annual MeetingSynlogic will present data on its phenylketonuria and homocystinuria programs at the Society for Inherited Metabolic Disorders 43rd Annual Meeting in Orlando, April 10-13, 2022. The presentations cover preclinical findings for SYNB1353 in homocystinuria and clinical data on SYNB1618 and SYNB1934 for phenylketonuria. The company expects to start a Phase 3 study for its PKU program in the second half of 2022.